Biostatistics and Clinical Innovation Industry and Regulator Forum

Gain access to novel, thought-provoking findings and collaborate with experts on charting the best path forward in biostatistics and clinical trial innovation.

Early Bird Ends

DAYS

HOURS

MINUTES

SECONDS

Send Email 1.888.257.6457

Back to Agenda

Session 3: Case Study Introduction of Subsequent Discussions

Session Chair(s)

Tamei Elliott, MS

Associate Director, Scientific Programs

DIA, United States

This Case Studies will showcase two compelling case studies highlighting innovative approaches to clinical trial design and execution. Each case study provides a deep dive into real-world applications, focusing on the challenges, solutions, and outcomes of cutting-edge methodologies in diverse therapeutic areas.

Learning Objective :
Understand the principles and benefits of master protocol designs and how they are applied in oncology trials
Identify innovative trial design strategies in neuroscience
Apply key learnings from these case studies to inform the design and execution of future clinical trials in your own therapeutic areas